melphalan hydrochloride for injection

DRUG2 trials

Sponsors

Peking University People's Hospital, CASI Pharmaceuticals (China) Co., Ltd.

Conditions

Multiple Myeloma

Phase 1

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

Peking University People's HospitalMultiple Myeloma

Start: 2022-10-13End: 2023-12-31Target: 24Updated: 2023-04-14

Phase 4

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

CompletedNCT06425276

CASI Pharmaceuticals (China) Co., Ltd.Multiple Myeloma

Start: 2020-07-24End: 2021-09-18Updated: 2024-05-23